Lineweaver Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-13,130
Closed -$378K 131
2023
Q4
$378K Sell
13,130
-51,768
-80% -$1.56M 0.1% 108
2023
Q3
$2.15M Buy
64,898
+2,263
+4% +$80K 0.63% 30
2023
Q2
$2.3M Buy
62,635
+1,192
+2% +$46.4K 0.66% 33
2023
Q1
$2.51M Buy
61,443
+6,912
+13% +$299K 0.77% 26
2022
Q4
$2.79M Buy
54,531
+6,201
+13% +$297K 0.85% 26
2022
Q3
$2.12M Buy
48,330
+9,308
+24% +$452K 0.69% 28
2022
Q2
$2.04M Buy
39,022
+4,387
+13% +$224K 0.68% 28
2022
Q1
$1.79M Buy
34,635
+7,938
+30% +$412K 0.51% 39
2021
Q4
$1.58M Buy
26,697
+4,076
+18% +$202K 0.45% 39
2021
Q3
$972K Buy
22,621
+1,295
+6% +$57.4K 0.3% 53
2021
Q2
$835K Buy
21,326
+3,713
+21% +$144K 0.27% 54
2021
Q1
$638K Buy
17,613
+6,773
+62% +$240K 0.23% 57
2020
Q4
$399K Buy
10,840
+292
+3% +$10.7K 0.16% 61
2020
Q3
$367K Buy
10,548
+1,471
+16% +$51.6K 0.16% 63
2020
Q2
$281K Buy
9,077
+1,150
+15% +$39.1K 0.14% 67
2020
Q1
$243K Buy
7,927
+2,272
+40% +$77.4K 0.15% 65
2019
Q4
$210K Buy
+5,655
New +$201K 0.12% 62

Other funds holding PFE